Science Explorer Back to mapMap
Discussion
Researcher · University of Virginia · United States

Deborah Ann Lannigan

Deborah Ann Lannigan publishes mostly in Molecular Biology, Oncology and Genetics, on topics such as Melanoma and MAPK Pathways, Estrogen and related hormone effects and Protein Kinase Regulation and GTPase Signaling.

ORCID 0000-0001-8380-9240 OpenAlex
World rank
#1,730,387
of 7,710,434 ranked researchers
Rank in United States
#534,099
of 1,627,098
Works
93
Citations
3.4k
Citations per work
36.3
h-index
27
i10-index 42Top 19% in Molecular Biology
Deborah Ann Lannigan

What does Deborah Ann Lannigan research?

Deborah Ann Lannigan's work is mostly in Biochemistry, Genetics and Molecular Biology (62%), Medicine (16%), Computer Science (3%).

Life Sciences: 58 works · 62.1% of their workBiochemistry, Genetics and Molecular Biology: 58 works · 62.1% of their workMolecular Biology: 49 works · 52.6% of their workGenetics: 9 works · 9.5% of their workHealth Sciences: 15 works · 16.3% of their workMedicine: 15 works · 16.3% of their workOncology: 13 works · 13.7% of their workPharmacology: 2 works · 2.6% of their workEverything else: 15 works · 15.8% of their workPhysical Sciences: 5 works · 5.8% of their workComputer Science: 3 works · 3.2% of their workComputational Theory and Mathematics: 3 works · 3.2% of their workChemistry: 2 works · 2.6% of their workOrganic Chemistry: 2 works · 2.6% of their workTHEIR WORKDeborah AnnLannigan93works
Life Sciences62%Physical Sciences6%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5862.1%
    1. Medicine1516.3%
  3. Everything else1515.8%
    1. Computer Science33.2%
    2. Chemistry22.6%
  1. 1Molecular Biology53% of their works
  2. 2Oncology14% of their works
  3. 3Genetics10% of their works
  4. 4Computational Theory and Mathematics3% of their works
  5. 5Organic Chemistry3% of their works
  6. 6Pharmacology3% of their works

Research topics

Which keywords describe Deborah Ann Lannigan's research?

The keywords of their largest research topics: Cancer Therapy, Oncogenic Mutations, Immune Response, BRAF gene, MAP Kinase, Transcriptional Regulation, Signaling and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Cancer Therapy462 topics
  2. Oncogenic Mutations462 topics
  3. Immune Response442 topics
  4. BRAF gene321 topic
  5. MAP Kinase321 topic
  6. Transcriptional Regulation292 topics
  7. Signaling232 topics
  8. Cancer202 topics
  9. Estrogen151 topic
  10. Receptor151 topic
  11. Protein Kinases141 topic
  12. Ras Signaling141 topic
  13. IL-6121 topic
  14. STAT3121 topic
  15. PI3K/AKT pathway81 topic
  16. mTOR81 topic
  17. Chromatin61 topic
  18. Molecular Docking61 topic
  19. Transcription61 topic
  20. Virtual Screening61 topic
  21. Cancer Stem Cells41 topic
  22. Tumor Metastasis41 topic

Where does Deborah Ann Lannigan work?

Deborah Ann Lannigan's main affiliation in the publication record is University of Virginia, United States.

How many publications and citations does Deborah Ann Lannigan have?

OpenAlex counts 93 works and 3,378 citations for Deborah Ann Lannigan, an h-index of 27, ranking #1,730,387 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Deborah Ann Lannigan. Posts are plain text and can be reported.